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A STRUCTURED REVIEW OF OUTCOME MEASURES USED FOR THE 
ASSESSMENT OF REHABILITATION INTERVENTIONS FOR SPINAL CORD 
INJURY. 
ABSTRACT (216 words) 
Objectives. To review the measurement properties of outcome measures of function or 
mobility currently used in the context of spinal cord injury (SCI). 
Methods. A keyword search of multiple databases to identify original papers. Papers 
were reviewed where they had included an evaluation, with people with SCI, of the 
psychometric properties of an outcome measure, which included functional or mobility 
domains. 
Information was extracted concerning item generation, ease and intended method of 
use, and scale properties, in particular: reliability, validity and responsiveness. 
Conclusions were reached concerning the psychometric properties of each instrument. 
Results.  Eight outcome measures were identified (plus adapted versions). Five had 
originally been developed specifically for evaluating patients with SCI (chiefly reflecting 
clinicians’ perspectives), the remaining 3 had not.  
The psychometric properties of the instruments varied, with some mixed/contradictory 
evidence likely relating to differing study sample sizes, characteristics and variable 
quality. Instruments also varied in stated purpose or emphasis. 
Conclusion. In addition to weighing evidence concerning measurement properties, users 
need to consider the stated purpose and item content of instruments in relation to their 
specific aims. With regard to the former, while reviewed instruments had some flaws, the 
Spinal cord Independence Measure (revised version III), Quadriplegia Index of Function 
(Short-form), Needs Assessment Checklist and SIP68 appeared the best, despite limited 
evidence of their responsiveness. 
2 
A STRUCTURED REVIEW OF OUTCOME MEASURES USED FOR THE 
ASSESSMENT OF REHABILITATION INTERVENTIONS FOR SPINAL CORD 
INJURY. 
INTRODUCTION  
The annual incidence of spinal cord injury (SCI) is estimated to lie between 10 
and 83 per million inhabitants per year and often results in catastrophic dysfunction and 
disability.1 Progress is gradually being made in the treatment of SCI to limit damage, 
prevent or treat complications prolonging survival, improve function, and enhance 
recovery. Any new interventions will likely include pharmacological, surgical and 
rehabilitation approaches, and all will require evaluations of their efficacy using 
appropriate outcome measures.2 
SCI is initially diagnosed in terms of the level at which the injury has occurred, 
which tends to equate with the observed degree of neurological and functional deficit. 
Nearly half of all spinal cord injuries are functionally incomplete, with some function 
preserved below the level of the lesion (although there is much variation between 
groups3). In such cases, the majority of people will likely experience useful recovery (to 
ASIA grade C or D4), including the ability to walk.5 Rehabilitation interventions and 
outcomes of SCI have thus tended to particularly focus on functional status.  
Since the mid-twentieth century, health status questionnaires and rating forms 
have been used to assess patients in a range of clinical settings, in order to document 
outcomes of care. These have usually been completed by health-care staff and primarily 
represented their perspectives. However, during the past two decades, health care has 
become more patient-centred, with measures emerging which assess the impact of a 
wide range of health care interventions, from the patient’s perspective6.  Such ‘patient-
reported outcome measures (PROMs)’ have gradually been introduced as an important 
outcome (or ‘end-point’) in randomised clinical trials and observational studies7. 
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For results to be meaningful, it is imperative that any measures used to assess 
outcomes in any health care context cover domains (e.g. pain, physical function, 
perceived independence) that are relatively specific and appropriate to a particular 
context or study aim. Evidence also needs to have been presented demonstrating that 
the questionnaire (and any associated scales) has acceptable measurement properties, 
including: reliability, validity, responsiveness, acceptability and feasibility.7 Another 
property that overlaps with reliability, validity and responsiveness, and which is 
particularly pertinent to measurement scales, is that of precision. In prospective outcome 
studies, such as a trial, the responsiveness of an outcome measure, that is, its ability 
accurately to detect change when it has occurred, is a particularly important aspect.8 
These stipulations apply to the SCI context no less than they do for any other condition.  
The purpose of this paper is to provide a structured review of instruments, that 
are widely used for the assessment of function or mobility in the context of SCI where 
they have also received any form of psychometric evaluation in that context. Evidence of 
their measurement properties is presented and non-scientific practical considerations 
are also highlighted to further facilitate clinical decisions.  
 
METHODS 
Search Strategy 
The following databases were searched for the years 1969-2006: National Library 
of medicine (Pub Med), Cochrane, CINAHL, and AMED. The search was limited to the 
English language. The term "spinal cord injury" was combined with the terms 
"classification or assessment, Index, Scale, outcomes measure or measurement, 
functional outcomes, mobility and functional assessment". Papers were selected by 
reviewing their titles and abstracts with additional references identified from the 
reference lists of selected papers. General search engines were used to access non-
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peer reviewed professional and specialist guidelines and workshops on Spinal Cord 
Injury websites such as the International Campaign for Cures of Spinal Cord Injury 
Paralysis, Spinal Cord Medicine, American Spinal Injury Association, the National 
Institution of Neurological Disorder and Stroke(NINDS Spinal Cord Injury), American and 
Canadian Spinal Research Organisation, International Spinal Injuries & Rehabilitation 
Centre (UK).   
 
Inclusion Criteria 
 Reports of any studies evaluating the use of an outcome measure to assess 
function or mobility in spinal cord injured patients were initially identified. Abstracts of all 
papers and titles were independently assessed by two reviewers (HA and DS) and 
agreement confirmed by a third (JD). Full copies of the selected papers were then 
obtained. Details of a measure were only included in the final review where some 
evidence of its psychometric properties had been published, which had been evaluated 
in the context of SCI.  
 
Data extraction 
 Using criteria for evaluating outcome measures described by Fitzpatrick et al 
(1998)7, data were independently extracted by three reviewers [DS, HA,JD]. Evaluation 
of measures gave particular consideration to the following criteria: 
Reliability - concerned with reproducibility and internal consistency. It assesses the 
extent to which an instrument is free from random error or the amount of a score that 
represents signal rather than noise. Test-retest reliability is designed to take account of 
variation over time in stable patients. The results of tests of internal consistency (eg. 
Cronbach’s alpha (α)) and test-retest reliability (eg. intra-class correlation, Bland-Altman 
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methods) are presented. Reliability estimates of α ≥ 0.7 are needed to claim internal 
consistency and are recommended for instruments intended for use at the group level7. 
Estimates need to be higher (α ≥ 0.9) where instruments are to be applied to 
individuals.9 
 
Validity - addresses whether an instrument measures what it is intended to measure.7 
The best evidence for validity involves assessing an instrument against a true value for 
the measure: a ‘gold standard’.10 In the SCI context, the American Spinal Injury 
Association (ASIA) Standards for Neurological Classification of Spinal Cord Injury4 is the 
most widely used and accepted method to evaluate and classify the level and degree of 
impairment of patients’ SCI.11  This system represents a ‘gold standard’ for assessing 
neurological (motor and sensory) impairment in SCI, but was not designed to assess 
functional ability or locomotion and does not therefore represent a ‘gold standard’ for 
assessing criterion validity of instruments focused on these domains. Thus, any 
evidence presented for the validity of instruments that involved comparisons with ASIA 
scores has been cited in this review as evidence of convergent or concurrent, rather 
than criterion, validitya.  
In the absence of a ‘gold standard’ for direct comparison, evidence for validity can 
take many forms. The source of instrument items and evidence for content and face 
validity may be presented, which can include qualitative examination of instrument 
content. Quantitative evidence derived from factor analysis or principal components that 
support dimensionality, or internal construct validity, is commonly presented. External 
construct validation generally includes comparisons with other instruments which may 
include standard clinical assessments.7  Frequently, this involves demonstrating that a 
measure is closely correlated with different measures of the same trait (‘convergent 
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validity’), or that a measure correlates little with measures intended to indicate a different 
trait (’discriminant validity’).9 
More recently, Rasch analysis: a more stringent assessment of underlying scale 
structure and dimensionality, is increasingly being undertaken.12 Rasch models test how 
well instruments conform to uni-dimensionality, hierarchy and interval location of items 
by examining patterns of individuals’ performance on the range of items in a scale and 
patterns of items’ difficulty or severity.7 
Responsiveness/Sensitivity - concerned with the extent to which an instrument is 
sensitive to meaningful changes in health status. This property is particularly important 
for instruments applied in clinical trials.9 Responsiveness preferably needs to be 
assessed in a prospective study, where change in health status is likely to occur for the 
majority. Here, effect sizes are commonly employed (other methods include using paired 
t-test comparisons or the responsiveness statistic8), which is a method of calculating the 
magnitude of change measured by an instrument in a standardised way which allows 
direct comparisons to be made between different instruments and scales.13  
 
RESULTS 
Instruments 
Table 1 lists details of any instruments identified as being widely used for the 
assessment of function or mobility in the context of SCI which had received any form of 
psychometric evaluation in that context, together with brief details of published studies 
contributing to that evidence.  
A total of eight instruments (plus modified versions) were identified, namely: the 
Barthel Index of Disability (BI)14 (Modified BI15); the Functional Independence Measure 
(FIM)16 (Adapted Turkish version17 and shortened version - the Fone FIM18); the 
                                                                                                                                                                                            
a This is irrespective of the term used in any cited articles. 
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Quadriplegia Index of Function (QIF)19 (Short-form QIF20); the Spinal Cord 
Independence Measure (SCIM)21 (revised SCIM22); the Walking Index for Spinal Cord 
Injury (WISCI)23; the Needs Assessment Checklist (NAC)24; the Spinal Cord Injury 
Functional Ambulation Inventory (SCI-FAI)25 and the Short Sickness Impact Profile 
(SIP68)26.  
In contrast to other measures cited in table 1, the BI, MBI, FIM (and adapted 
versions) and the SIP68, were not originally designed to assess patients with SCI 
specifically, (although the SIP68 developmental study included 5% SCI patients), but 
were instead designed for application in a range of rehabilitation settings. While the 
psychometric properties of the BI and MBI have been evaluated within a number of 
contexts (eg. older people, stroke patients), few details of any such evaluations could be 
found involving SCI patients, apart from within a study involving a Turkish translation of 
the MBI.27 This latter version had items altered to suit different cultural norms, which also 
risked altering their meaning from earlier English formats (although psychometric 
reassessment was formally conducted).  
By contrast with the BI and MBI, the original FIM has been assessed in a number 
of studies with SCI patients28 29-31, as have the more recent adapted versions17 18;32;33 of 
the FIM. The SIP68 has also been evaluated with SCI patients in two studies with 
relatively large sample sizes34;35. 
 Instruments that were designed specifically to assess the function or mobility of 
SCI patients are: the Quadriplegia Index of Function (QIF) 19;36 and Short-form QIF20; the 
Spinal Cord Independence Measure (SCIM)21 and Catz-Itzkovich revised SCIM 22; the 
Walking Index for Spinal cord injury (WISCI)23; the Needs Assessment Checklist 
(NAC)24, and the Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI)25. 
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Item generation 
While the precise formal method of item generation was rarely specified 
(exceptionally, originators of the WISCI specify using a modified Delphi technique23), the 
majority of instruments were devised by health care providers. Only the SIP68 appeared 
to have involved patients and their carers37 in the initial process. Two instruments 
(WISCI23, SCI-FAI25) used blinded ratings of videotaped footage of patients to aid 
consensus within a research team, after a list of candidate items had been produced. 
Computerised techniques (regression or principal components analysis) were employed 
to select/reduce items to produce the Short-form QIF20 and the SIP6837. The former also 
involved interviews with patients at this stage. 
As well as being chiefly designed by health care providers, the majority of 
instruments were designed to be used by clinical raters. While this generally did not 
preclude gaining input from patients and carers, many of the instruments also had quite 
complex scoring systems requiring raters to undergo training in their use and 
interpretation. The minority of instruments that could be self-rated were: the FIM16 
(particularly, the adapted version38) and shortened Fone-FIM18, the NAC24 and the 
SIP6837. 
 
Measurement properties of instruments within the SCI context  
(summarised in table 2) 
Table 2 provides details of the measurement properties of instruments tested in 
the context of SCI, reported by studies cited in table 1. 
The BI, FIM and SCIM appeared to have been used with SCI patients most often, largely 
reflecting the greater length of time that had elapsed since first publication. This did not 
necessarily indicate a greater degree of instrument evaluation having occurred in the 
SCI context. 
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Ceiling/floor effects 
In many cases (BI, QIF, SCIM, SCI-FAI) little formal evidence had been 
presented concerning overall score floor or ceiling effects. In all other cases, clustering 
of extreme values (allowing for no further improvement or deterioration to be measurable 
on subsequent assessment) commonly occurred in some subscales eg. cognitive scale: 
FIM 30 17; communication scale: FIM 30 17 and SIP6835; stairs: MBI27; mobility: SCIM-III3 
and SIP6835; walking: WISCI39;40. An item-level analysis of the BI noted the presence of 
floor or ceiling effects for some items, including feeding and grooming, at admission or 
discharge.41 
 
Reliability 
No evidence of the internal consistency of the instrument or subscales could be 
for the BI, QIF, WISCI or SCI-FAI. Evidence of adequate internal consistency 
(Cronbach’s α >0.7) was reported for all other measures apart from the FIM locomotion 
(Cronbach’s α 0.4)42 and SIP68 emotional stability (Cronbach’s α 0.68)34 subscales. 
Evidence of optimal internal consistency (Cronbach’s α range 0.80 to 0.90) was reported 
for the Turkish MBI27, Short-form QIF20, NAC (most subscales)24;43 and SIP68 (all but 
one subscale)34.  
Test retest reliability (TRT) (assessing the same rater’s responses on different 
occasions) had not been assessed in relation to the QIF, the short-form QIF, The WISCI, 
or the SCI-FAI. TRT assessment of the NAC, had used correlations alone (correlation is 
inadequate, as it is not a test of agreement), which produced high values r ≥ 6.924. TRT 
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reliability (using Kappa or ICC) was good (K values 0.61 - 0.80, or ICC values >0.70) for 
the MBI27, SCIM44, SCI-FAI25 and SIP6835.  
Evidence for inter-rater (or observer) reliability was not found for the BI, short-
form QIF, NAC or SCI-FAI. Assessments of the QIF and FIM (patient versus clinician 
rating compared in the latter case) used correlations alone, which were moderate to high 
(r range 0.55 - 0.95)19;29. Using Kappa, ICC or Kendall coefficient of concordance45, the 
FIM (Turkish version)17 and SCIM-II produced some moderately low values (<0.5)44; the 
MBI27 had moderate to good levels of inter-rater reliability (K values > 0.5)27, with very 
high values (K values 0.81 - 1.00 or ICC values >0.90) presented for the SCIM-III22. 
 
 
Validity 
Given the absence of any ‘gold standard’, correlation comparisons between other 
measures (purporting to measure a broadly similar construct) were taken to denote 
evidence, or otherwise, of convergent, concurrent or discriminant validity. Results of 
Principal (factor) components, or alternatively Rasch analysis, supporting underlying 
scale structure were taken as evidence of construct validity. 
Evidence of acceptable concurrent validity was found with the FIM46; and for 
some sub-scales, some of the time, representing the FIM Turkish version17, MBI 
(Turkish version)27, short form QIF20 and SIP6834.  
Evidence of construct validity could appear inconsistent or contradictory in some 
instances. Thus, Rasch analysis revealed problems concerning disordered thresholds 
(grooming and stairs items) and model misfit affecting bladder and bowel items in the 
FIM motor domain17;31, (bladder and bowel items in the MBI Turkish version were also 
associated with considerable levels of misfit in Rasch analysis27), that appeared to be 
accentuated in cross-cultural comparisons30; while evidence from factor analysis, 
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produced an unproblematic two-factor solution (together using all 18 items), with each 
scale further associated with a high level of internal consistency (itself a form of 
convergent validity)47.  
Findings from Rasch analysis highlighted some flaws relating to construct validity 
for the SCIM version III, with ‘walking outdoors’ and ‘stair management’ items within the 
mobility subscale, and ‘toilet use’ within the respiration/sphincter subscale exhibiting 
misfit. The latter subscale also contained some items with disordered category 
thresholds eg. bowel management.3 22 Factor analysis on the SIP68 represented data 
from a heterogeneous (mainly non-SCI) population and was therefore considered largely 
inappropriate, and no evidence of construct validity (note that absence of evidence is not 
synonymous with evidence of absence) was found for the BI, the QIF (or short-form 
QIF), the SCIM (early version), the WISCI, the NAC, or the SCI-FAI.  
 Evidence of convergent validity (correlations) was presented for most instruments 
in relation to other instruments purporting to measure something similar. Thus the short-
form QIF score correlated with the Upper Extremity Motor Score (r> 0.8)20; the SCIM 
with the FIM (r> 0.8)21;48, the WISCI (r=0.97)49 and with the NAC (r=0.47 to 0.85)24. 
Considerable evidence of convergent validity was presented for the WISCI: with the FIM 
(r≥ 0.7)23;49, the LEMS(r=0.47 to 0.91)50, the Berg Balance Scale39, the BI and 
Rivermead mobility index (both r=0.67)49, and the SCIM (r=0.97)49. The NAC correlated 
with the WISCI and the Hospital Anxiety and Depression Scale (HADS) (r=0.47 to 
0.85)24; the SCI-FAI with gait scores, walking speed (r≥ 0.7) and the Lower Extremity 
Motor Score (LEMS) (r>0.6)25; and the SIP68 correlated with relevant domains of the 
SF-36 (r≥ 0.57), ADL (somatic autonomy r=0.81)35, and with the BI (r=0.54 to 0.91)34. 
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Responsiveness 
 Evidence of good responsiveness was found for the BI and FIM motor scale (both 
had effect size 0.9, comparing scores between patients’ admission and discharge 
dates)19. There was other (weaker) evidence suggesting that the FIM was less sensitive 
than the QIF46;51); that the FIM was similar to the BI51, the QIF was better than the BI19 
and the FIM46. The original SCIM and SCIM version III were each found to be superior to 
the FIM21;52;53 and the WISCI was possibly superior to the (Locomotor Functional 
Independence Measure) LFIM and SCIM39 and had superior sensitivity to walking 
recovery than the BI, RMI, SCIM, LEMS or FIM49. Few studies used effect sizes and 
overall, evidence of responsiveness was generally quite weak. There was no evidence 
concerning the responsiveness of the MBI, the short-form QIF, the NAC, or the SIP68 in 
the SCI context. 
 
DISCUSSION  
This review focussed on instruments that are widely used to assess function or 
mobility in patients with SCI, which have also received some form of psychometric 
evaluation in that context, and complements and extends the scope of previous reviews 
in this area54-57. Eight instruments were identified, together with adapted or shortened 
versions. There were two main findings. 
The first finding was that, with the exception of the SIP68, none of the measures 
identified had involved interviews with any patients at all, at the design stage, for the 
purpose of item generation. This finding naturally leads to the conclusion that current 
measures may not represent SCI patients’ perspective, but more likely represent the 
perspective of clinicians.  
 Patients increasingly expect to be involved in decisions about their care and to 
receive accurate information to facilitate their involvement58. Thus, the use of 
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instruments that represent chiefly the clinician’s perspective might be considered 
inappropriate by some, or only appropriate in certain circumstances or in relation to 
particular domains. Nonetheless, the extent to which patients are involved at all, even in 
rating the different instruments, remains generally quite limited.  
 Variation in the extent to which patients are involved in rating questionnaires 
could be influenced by a number of factors. For instance clinicians may (not 
unreasonably) believe that patients’ and clinicians’ ratings of their functioning will differ, 
but may also assume that clinical observers will provide more objective and accurate 
scores. Indeed it has been asserted by Itzkovich et al 44 that direct observation of 
individuals’ functioning is more accurate and less subject to bias than patients’ self-
reports because patients may have unrealistic or uninformed expectations, particularly in 
relation to goal-setting and achievement. Their score ratings for the SCIM have therefore 
tended to rely entirely on observations rather than subjective reporting. However, results 
from a small-scale study, by the same authors, found that any differences between 
patients’ ratings obtained by interview and ratings produced by observers actually 
appeared insignificant.44 The extent to which patients are involved in rating 
questionnaires may also relate to the intended purpose of the instrument. Thus, by 
contrast with the SCIM, the NAC is more concerned with measuring individuals’ 
rehabilitation success in achieving set goals and patients are invariably involved in rating 
questionnaire items.59;60 However, item ratings on the NAC differ in another way from 
the SCIM (and other measures), in that no distinction is made between someone being 
able to carry out a task verbally (by asking someone to do it for them) versus carrying 
out the task themselves. Berry et al defend this, believing that a patient with a higher 
level of injury should be able to achieve independence, through others, by articulating 
their own needs. They also argue that, while the patient’s perception of their 
independence might be at the cost of accuracy, their active involvement in the process 
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engenders compliance. 59;60 Others have also noted that perceived control has the 
strongest association with life satisfaction.33 These arguments appear reasonably 
compelling where outcome measures are used for the purpose of individual goal-setting, 
but are problematic in other contexts eg. trials comparing outcomes of different 
interventions. 
Clearly while current measures mainly represent clinicians’ perspectives, this 
does not mean that all clinicians share the same perspective (many of these issues have 
been discussed elsewhere.54;55) This nonetheless still leaves the question of whether 
there is a need for a new self-reported measure to be developed for SCI, that fully 
represents patients’ perspectives. 
 Our second main finding was that the quality of evidence for the psychometric 
properties of instruments reviewed was very variable, occasionally quite poor. Evidence 
for responsiveness, particularly evidence of instruments’ ability to detect meaningful 
change was particularly lacking. Evidence of instruments’ psychometric properties also 
sometimes appeared to be conflicting (eg. different studies’ evidence for construct 
validity). There are a number of likely reasons for this. In the first instance, it is only 
since the early to mid 1990s that a well-described psychometric methodology has 
become established for developing and reporting health status questionnaires, that is 
applicable to clinical situations.61 A number of the instruments here reviewed, were 
produced and assessed prior to the mid-1990s.  
A possible reason to explain apparently conflicting findings - particularly regarding 
construct validity - is that different statistical procedures, such as factor analysis 
(representing Classical Test Theory) versus Rasch analysis, have fundamentally 
different requirements. For instance, instrument scales that arise through application of 
factor analysis are treated as interval scales, when they are generally based on ordinal 
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level item scoring; while the Rasch model - to which a scale is compared in Rasch 
analysis - is a more stringent test, as it is a statistically proven interval scale.62  
While Rasch analysis may be regarded as more stringent than conventional 
psychometric analysis, the context of its application remains important, as is the case 
with classical psychometric methods, Thus another reason why evidence from different 
studies might differ relates to differing sample sizes and composition relating to age, 
gender; the range, extent and type of SCI; as well as the context in which studies have 
occurred - often varies from one study to the next. This is important because the 
measurement properties of an instrument are not just of the instrument: they are of the 
instrument pertaining to the population and context in which they are developed, and 
tested.61 Thus, if a measure is designed and calibrated with one group of patients, its 
measurement properties may change if applied to a different group of patients, such as 
those representing different age-groups or different clinical characteristics. The use of a 
measure in a different context from the original developmental study (eg. a hospital pre- 
post-surgical context versus the context of community based rehabilitation) can also 
affect the measurement properties.  
This leads to the issue of how health and social care providers are to choose 
between instruments designed for assessing outcomes of interventions for SCI, and 
whether this review can support particular recommendations.  
There will never be a perfect questionnaire or measure of outcome and efforts to 
produce one risks a proliferation of imperfect examples from which assessors and 
trialists must then choose, which is to be discouraged. Choosing the right measure 
involves identifying the most appropriate measure for the chosen patient group, context 
and purpose, where evidence exists to show that the questionnaire has exhibited 
adequate measurement properties pertaining to a similar patient group and context.  
16 
Of those instruments reviewed, if a generic measure is considered to be 
appropriate for a particular purpose, then, of the BI/MBI, FIM, and SIP68 generic 
measures, the SIP68 has the best measurement properties. However, evidence for its 
responsiveness has not been evaluated within the SCI context, only once this has 
occurred can its use in clinical trials be sanctioned.  
Regarding SCI condition-specific, multidimensional measures (ie. that comprise 
different dimensions represented by a number of sub-scales), which aim to cover the full 
range of SCI; of these the SCIM and the NAC had comparable measurement properties. 
These were mostly good, although a few shortcomings concerning some subscales of 
the SCIM-III, based on Rasch analysis, may indicate the need for further refinements.3 
The responsiveness of the NAC has also not been assessed. However, as the NAC and 
the SCIM each reflect somewhat different (although likely related) constructs, and are 
each applied in different ways, choosing between these instruments depends crucially 
on the purpose that any potential user has in mind.  
Where highly-specific measures are required, for the assessment of 
mobility/ambulation alone, the WISCI and SCI-FAI are both supported by evidence for 
acceptable levels of reliability, validity and responsiveness. The only caution concerns 
their use with low level quadriplegic subjects with whom ceiling effects are likely.  
For the assessment of patients with quadriplegia, the QIF has good measurement 
properties generally. The short form QIF has particularly high levels of internal reliability 
and could therefore be used to assess progress in individual patients, which is not the 
case for any of the other measures reviewed - excepting the Turkish versions of the FIM 
and MBI - no other measures had sufficiently high reliability to permit this application, 
and they are therefore only suitable for making group comparisons.63  
 While conducting this review, we considered whether SCI represents a 
particularly challenging area for outcomes measurement. For instance, as others have 
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noted56, SCI is a heterogeneous disorder in terms of level and severity of injury, and it is 
unsurprising that most measures will exhibit floor or ceiling effects when applied to 
groups of patients that largely represent one or other extreme end of the spectrum of 
injury. If ‘broad spectrum’ measures are considered appropriate, then this particular 
‘flaw’ may need to be accommodated. In addition, traumatic SCI may be accompanied 
by other injuries. These have the potential to produce considerable amounts of ‘noise’ 
where the measurement of change in function is specifically concerned with 
interventions directed towards the SCI. We suggest that there are no simple means of 
dealing with these substantial challenges.  
 Recent developments in psychometric theory offer the opportunity to develop item 
banks which can be retained on computer. Patients can then complete items on-line 
and, on the basis of their responses to certain items, computer-adaptive testing will 
select the most appropriate items for them to complete thereafter. This method can 
reduce patient burden as it leads to fewer items being asked.64 Whether such methods 
offer other improvements in SCI assessment remains to be evaluated. 
 Generally, the use of condition-specific measures with adequate measurement 
properties is clearly necessary in the context of SCI; but even this is not sufficient if 
outcome studies are to produce meaningful data. This requires using such measures to 
be complemented by rigorous planning and conduct of data collection methods, with 
outcomes data obtained at appropriate points in time, relative to a meaningful date: 
defined and operationalised in the same manner for all subjects. Study sample sizes 
also need to be adequate.  
The process of conducting this review revealed that, if applied appropriately, 
while never perfect, a number of outcome measures that are currently available are 
likely good enough.  
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Table 1. Health status instruments used for the assessment of outcomes of care for spinal cord injury, that have been evaluated, in that context, for any of their psychometric properties. 
 
Instrument/ 
Developmental 
study 
 
 
Context in which 
instrument first 
designed and 
used 
 
Domains, number of 
items (n), scoring 
system 
 
Method of item 
generation 
 
Intended method of 
use 
 
 
Studies involving 
instrument evaluation 
with SCI patients 
 
Setting(s) /study population(s) (n, sex, 
mean age) relating to studies involving 
instrument evaluation with SCI patients 
       
Barthel Index of 
disability(BI) 
Mahoney F, Barthel 
D. 1965. 14 
 
 
 
Chronic disease 
hospitals - 
patients with a 
neuromuscular or 
musculoskeletal 
disorder i.e. not 
SCI-specific. 
 
1 functional disability 
domain. 
10 (individual ADLs -
mobility, basic self 
care) 2 or 3 response 
options. 
Total score 0 to 100 
points (0= highest 
dependency). 
Devised by health 
care providers. 
Method unclear. 
 
 
  
 
 
 
Administered 
(assessed) by nurse, 
physio or doctor 
providing care - (+/- 
input from patient, 
relatives etc) 
 
 
 
Cano, 2006 51  
 
 
 
 
O’Connor et al 200441 
 
237/1396 patients had ‘spinal syndromes’. 
Analyses combined diagnostic groups 
(results similar  for all) 57% male, mean 
age 52 (SD 16) 
 
237 (17%)/1418 patients at a 
neurorehabilitation unit had SCI, of whom 
57% male, mean age 52 (range 16-85). 
       
Modified Barthel 
Index (MBI-II)* 
Shah S. 198915 
 
*MBI version I65 not 
evaluated with SCI. 
Patients with 
stroke referred for 
in-patient 
rehabilitation i.e. 
not SCI-specific. 
 
1 functional disability 
domain. 10 (individual 
ADLs -mobility, 
domestic & self care). 
5 response options. 
Total score 0 to 100 
points (0= highest 
dependency). 
Same items. 
Response options 
expanded by 
occupational 
therapists. 
Administered (rated) 
by nurse, physio or 
Dr providing care. - 
(+/- input from pt, 
relatives etc) 
 
Kucukdeveci A. et al 200027 
minor modifications to 
wording during translation 
process (into Turkish). 
Measurement properties re-
evaluated. 
Hospital in-patients: 50 with stroke and 50 
with SCI. Stroke patients: 74% female, 
mean age 58. SCI patients: 56% female, 
mean age 32. Level of injury for SCI 
patients: cervical 22%, thoracic 46%, 
lumber 32%. 
 
 
Functional 
Independence 
Measure (FIM)  
Hamilton BB et 
al.1987.16 
 
 
 
 
Designed for 
disabled people in 
general i.e. not 
SCI-specific. 
 
 
 
 
 
 
 
 
6 areas of functioning, 
18 items. Initially 4, 
then 7 level scale 
score range 1 to 7, 1= 
total assistance 
(poorest score) score. 
Max score 126. 
 
 
 
 
Task Force of clinical 
professionals - 
mainly associated 
with rehabilitation. 
 
 
 
 
 
 
Assessment by 
clinical raters 
(especially when 
involving in-patients) 
or by self-report 
 
 
 
 
 
Karamehmetoglu et al 
199729 
Lawton et al 2006 30 
 
Lundgren-Nilsson et al 
200631 
 
Yavus et al 199846 
 
50 in-patients with SCI: 22% tetraplegic, 
78% paraplegic. 76% male, mean age 40. 
647 SCI patients at 19 rehabilitation 
facilities. 69% male, mean age 46. 
471 patients at 9 rehabilitation facilities: 
included 157 with SCI. 70% male, age 
range 11-90. 
29 tetraplegic patients admitted to 
rehabilitation centre. 67% male, mean age 
37 range 14 - 66. 18 complete, 11 
incomplete SCI. 
FIM Adapted 
version38/ 
Involves a patient 
classification 
system 
Subscale scores 
combined into two 
motor and cognitive 
domains 
 
Same items Ditto Stineman, 199647,  
Cano, 2006 51  
 
Heinmann, 1991 38 
1831 SCI patients discharged from 
rehabilitation units/hospitals. Mean age43. 
237/1396 patients had ‘spinal syndromes’. 
Analyses combined diagnostic groups 
(results similar  for all) 57% male, mean 
age 52 (SD 16) 
Shortened form/ 
‘the Fone FIM’ 
adapted for self-
report18 
   Self-rated by patient Grey and Kennedy 199332 
 
 
Fuhrer et al 199233 (using 
shortened form ‘antecedant 
of the Fone FIM’ 
40 hospital in-patients with traumatic SCI. 
32% tetraplegic, 68% paraplegic. 
85% male. Mean age 30. 
140 community based people with SCI. 
41% quadriplegic, 43% paraplegic, 16% 
incomplete. 71% male, mean age 37. 
/Table 1 continued 
 
Instrument/ 
Developmental 
study 
 
 
Context in which 
instrument first 
designed and 
used 
 
Domains, number of 
items (n), scoring 
system 
 
Method of item 
generation 
 
Intended method of 
use 
 
 
Studies involving 
instrument evaluation 
with SCI patients 
 
Setting(s) /study population(s) (n, sex, 
mean age) relating to studies involving 
instrument evaluation with SCI patients 
       
Turkish adapted 
version 
17 
 
Ditto - translated/ 
adapted for use in 
Turkey. 
 
2 major domains: 13 
motor and 5 social-
cognitive function 
items 7 level scale 
 
Minor word changes 
/translation by health 
care professionals 
and translators. 
 
Assessment by 
clinical raters 
 
Kucukdeveci et al17 
 
50 patients with stroke & 50 with SCI. 
The latter: 56% female mean age 31.5. 
 
 
       
 
Quadriplegia 
Index of Function 
(QIF)  
Gresham GE  et al. 
1980 36; 1986.19 
 
Patients with 
Quadriplegia 
(complete lesion) 
 
 
 
 
45 items for 10 areas 
of self-care & mobility. 
7 areas scored on 5 
point scale. Final 
score produced from 
37 items with 
weighting system. 
 
Devised by 
experienced 
multidisciplinary SCI 
team. 
 
 
 
Assessment by 
experienced clinical 
raters. 
 
 
 
 
Gresham GE et al. 1986. 19 
 
 
 
Yavuz et al 199846 
 
30 quadriplegic patients, of whom 20 rated 
by independent raters. No other sample 
details provided. 
 
29 tetraplegic patients admitted to 
rehabilitation centre. 18 complete, 11 
incomplete SCI. 67% male, mean age 37 
range 14 - 66.  
       
Short-form QIF 
Marino & Goin 
199920 
Patients with 
tetraplegia. 
6 items (no weighting) Original items 
reduced, using 
interviews with 
patients and 
regression analysis. 
Assessment by 
clinical raters 
 
Marino & Goin 199920 95 tetraplegic patients. 89% male mean 
age 31. 
 
Spinal Cord 
Independence 
Measure (SCIM) 
Catz A et al. 
1997.21 
 
Patients with 
tetraplegia or 
paraplegia. 
 
 
 
 
4 domains/subscales, 
comprising 16 items. 
(scoring: self-care 0-
20; respiration & 
sphincter 
management  0-40; 
mobility 0-40). 
 
Devised by specialist 
health care 
providers. Method  
not stated. 
 
 
 
Assessment by 
clinical raters 
 
 
 
 
 
Catz A et al. 1997.21 
 
 
 
 
30 patients: 9 tetraplegic, 21 paraplegic. 
73% male, mean age 45. 
 
 
 
       
Catz-Itzkovich 
revised SCIM  
Catz A et al. 
2001.52 
 
Patients with 
tetraplegia or 
paraplegia. 
3 subscales/18 items: 
self-care 0-20; 
respiration & sphincter 
0-40; mobility 0-40. 
Revised wording to 
scoring system by 
specialist health care 
providers. 
Assessment by 
clinical raters 
 
 
Catz A et al. 2001.52 
 
 
 
 
28 patients:  
6 tetraplegic and 22 paraplegic. 
64% male, mean age 46. 
 
 
 
Catz-Itzkovich 
revised SCIM  
(SCIM III)3 
Patients with 
tetraplegia or 
paraplegia. 
3 subscales/19 items 
Scoring - as above. 
Refinements to 
address intercultural 
biases. 
Assessment by 
clinical raters 
 
 
Catz A et al 20073 
Itzkovich M. et al. 2007.22 
425 patients representing 6 countries. 188 
tetraplegic, 237 paraplegic. 73% male, 
mean age 47. 
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ich Me Inte Setting(s) /study
 
Instrument/ 
De l 
study 
 
velopmenta
 
Context in wh
instrument first 
designed and 
used  
 
Domains, number of 
items (n), scoring 
system 
 
thod of item 
generation 
 
d mende thod of 
use 
 
 
 inStudies volving 
instrument evaluation 
with SCI patients 
 
 population(s) (n, sex, 
mean age) relating to studies involving 
instrument evaluation with SCI patients 
 
Walking Index for 
Spinal cord injury 
(WISCI) 
Ditunno JF Jr et al. 
2000. 23/ 
Walking Index for 
Spinal cord injury 
(WISCI II)66 
 
 
Patients with 
spinal cord injury 
in a rehabilitation 
setting. 
 
1 hierarchical scale 
representing 19 levels 
of walking limitation 
(includes use of aids 
and assistance) over 
10 metres. 
One extra level added 
to scale in WISCI II. 
 
Modified Delphi 
technique (clinical 
experts). Consensus 
reached using 
blinded ratings of 
videotaped 
examples. 
 
Assessment by 
observers, 
particularly for use in 
the context of clinical 
trials. 
 
Ditunno JF Jr et al. 2000. 23 
 
Morganti B et al. 2005.49 
 
 
Ditunno JF Jr et al. 
2007{4106) 
 
Ditunno JF Jr et al. 
2007{4105} 
 
Ditunno, PL et al. 2001 66 
 
Van Hedel, HJ et al 200567 
 
Video segments ‘representative group’ of 
40 patients. 
284 patients, 65% male, mean age 50. 
38% traumatic aetiology. Wide range of 
SCI (using ASIA grading). 
150 SCI patients USA & Europe - but full 
assessment on n=77. Few details of 
sample characteristics. 
146 patients from 6 regional SCI 
rehabilitation centres. 78% male, mean age 
32. Asia gradings B, C, & D. 
Retrospective analysis. 103 patients. Few 
details given. 60% male. 
75 SCI patients able to walk selected from 
all SCI patients attending one hospital for 
rehabilitation or ambulation check-up.  
 
Needs 
Assessment 
Checklist (NAC) 
Kennedy P and 
Hamilton LR. 
1999.24 
 
Patients with SCI 
in a rehabilitation 
setting. 
 
9 core domains, with 
216 behavioural 
indicators (since 
reduced to 199). 4 
levels of scores (0-3) 
(0: totally dependent, 
3: totally independent) 
 
Devised by specialist 
health care 
providers. Methods  
not stated. 
 
 
Self-rated or 
administered by key 
worker with the 
patient to facilitate 
individual 
assessment and goal 
setting. 
 
Berry C & Kennedy P. 
2002.59 
 
 
 
Kennedy P et al 200343 
 
Tertiary care SCI centre. 43 patients, 88% 
male, mean age 42. 14% complete 
tetraplegia, 37% incomplete tetraplegia, 
23% complete paraplegia, 26% incomplete 
paraplegia.  
192 newly injured SCI patients. 77% male, 
mean age 41. Wide range of extent of 
injuries. 
 
The Spinal Cord 
Injury functional 
Ambulation 
Inventory (SCI-FAI) 
Field-Fote E et al. 
2001.25 
 
Patients with 
incomplete SCI in 
a rehabilitation 
setting. 
 
Three key domains of 
walking function in 
individuals with SCI: 
gait parameters, 
assistive device use 
and timed walk. 
 
Devised by 10 
specialist physical 
therapists based on 
viewing & ranking 
videotapes. 
 
Assessment by 
clinical rater. 
 
Field-Fote E et al. 2001. 25 
 
 
 
 
Videotapes of walking from 10 patients with 
incomplete SCI. Instrument assessed 
further on 22 patients with incomplete SCI. 
77% male, mean age 32. 
 
 
The SIP68 
De Bruin AF et al. 
199437  
 
 
Patients 
representing 10 
different 
diagnostic groups 
including 41/835 
(5%) with SCI 
 
Six domains, 68 items 
(statements). Scores 
produced through 
simple addition of 
ticked (yes/agree=1) 
items. (No weightings) 
High score=worse 
problems. 
 
Original SIP items 
developed with input 
from patients, carers, 
clinicians. 
Item reduction for 
SIP68 using principal 
comp’t analysis. 
 
Self-completion or 
assisted by interview 
(including by 
telephone). 
 
De Bruin AF et al. 199437 
 
Post M et al 199634 
 
 
 
Nanda U et al 200335 
 
N=835 subjects from 10 diagnostic groups. 
41/835 5% with SCI.  
315 patients interviewed at home 4-10 
years following rehabilitation at one 
specialised centre for varying degrees of 
SCI. 75% male, mean age 39. 
398 patients with various disabilities 
including 40 (10%) with SCI - all male. 
/table 1 continued 
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Table 2. Summary of measurement properties of health status instruments cited in table 1,  where (if) evaluated in the context of spinal cord injury. 
 
RELIABILITY 
 
VALIDITY 
 
 
 
Instrument 
 
Number of 
published 
studies where 
instrument has 
been used with 
SCI patients 
 
 
 
Ease of use 
1-3a
 
 
 
Floor (Fb )/ 
Ceiling (C) 
effects 
Internal 
consistency 
(Cronbach’s 
alpha(α)) 
Test/re-test 
(ICC) or 
Kappa (K) 
Inter-rater 
or inter-
observer  
 
Construct, convergent, concurrent  
or discriminant.. 
 
RESPONSIVENESS/ 
SENSITIVITY 
 
 
Barthel Index of 
disability(BI) 
Mahoney F, 
Barthel D. 1965. 
14 
/BI modified 
scoring system 
Shah, 198915 
 
>10 
 
3 
 
 
 
 
 
Overall F/C 
effects likely51 
but limited 
evidence. 
Item level F & 
C effects 
noted eg. 
feeding41 
 
No evidence 
in SCI context 
 
No evidence in 
SCI context. 
 
No evidence 
in SCI 
context. 
 
No evidence in SCI context. 
 
Limited comparative 
evidence in SCI 
context 
suggesting less 
sensitive than the 
QIF.19 
Similar effect size to 
FIMmotor.51 
         
Modified 
BI (MBI) - 
Turkish 
version27 
 
1   3
 
Floor effect -
stairs item. 
 
0.88 at 
admission, 
0.90 at 
discharge27 
0.77 (ICC) 27 Kappa >0.527 Construct Rasch model: misfit to 
construct for bladder and bowel items. 
Convergent Overall agreement (Kruskal 
Wallis test) with ASIA impairment scale 
p≤ 0.005 at admission and discharge. 
Items’ correlation with ASIA scores: 
ASIA motor scale: range r 0.25 to 0.69, 
ASIA sensory scale: range r 0.17 to 
0.63.27 
No evidence in SCI 
context 
 
         
 
Functional 
Independence 
Measure (FIM) 
.16 / 
Adapted FIM (2 
scales)/ 
Shortened form 
‘the Fone FIM’ 
18 33’ 
 
 
 
>10 
 
 
 
 
 
 
 
3 
 
 
 
 
 
 
Substantial 
ceiling effect 
with cognitive 
scale.30 
Lesser F/C 
effects than 
BI51 
 
Locomotion 
subscale low 
α 0.442 
Motor 
subscale α 
0.94 
Cognitive 
subscale α 
0.9047 
 
 
 
 
 
Repeated 
measures on 
two sites of 
one sample.68 
 
 
 
 
 
 
 
 
 
Patient 
interview 
versus 
observation 
by clinician 
Spearman r 
= 0.94.29 
 
 
 
Concurrent Statistically significant 
(trend) score decrement between 
patients with varying ASIA levels.46. 
Construct Rasch model: misfit to 
construct for bladder and bowel items.31 
17 
Rasch analysis: scoring system invalid 
in cross-cultural comparison.30 
Convergent Low correlation between 
cognitive subscale and formal 
neuropsychological testing.69 
Construct Factor analysis supported 
motor & cognitive dimensions.47 
 
Comparative 
evidence 
Suggesting FIM  less 
sensitive than the 
QIF.46 
 
Motor subscale effect 
size 0.90 between 
admission and 
discharge=similar to 
BI.51 
         
FIM Turkish 
version17 
1 3 Ceiling effect  
with 
communication 
& cognitive 
subscales. 
17 
Overall Motor: 
α 0.93 
Overall 
Cognit.: α 
0.98.17 
Motor: 0.90 
Cognit.:0.98. 
17
 
Kappa 
>0.48.17 
Convergent Varied correlations 
(range0.02 soc cognit to 0.58 sphincter) 
between FIM motor scores & ASIA 
motor/sensory scores. No correlation 
between FIM cognit. scores & ASIA 
motor/sensory scores.17 
Statistically 
significant score 
changes between 
admission and 
discharge.17 
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 RELIABILITY 
 
VALIDITY 
 
 
 
Instrument 
 
Number of 
published 
studies where 
instrument 
used with SCI 
patients 
 
 
 
Ease of use 
1-3a
 
 
 
Floor (Fb )/ 
Ceiling (C) 
effects 
Internal 
consistency 
(Cronbach’s 
alpha) 
Test/re-test 
(ICC) or 
Kappa 
Inter-rater 
or inter-
observer  
Construct, convergent, concurrent  
or discriminant.. 
 
RESPONSIVENESS/ 
SENSITIVITY 
 
         
Quadriplegia 
Index of 
Function (QIF)  
36 
At least 5 3 No evidence 
found. 
 
No evidence 
found. 
 
No evidence 
found. 
 
Pearson (r) 
range 0.55 to 
0.95 between 
3 raters’ 
scores (all 
p<0.001).19 
Convergent Statistically significant 
correlations, range r=0.64 to 0.91, 
between QIF scores & ASIA motor, light 
touch & pinprick scores.46  
Evidence of superior 
responsiveness to 
the BI19 and the 
FIM.46 
 
         
Short-form QIF 
20
 
1   1 Ceiling effect
in subjects 
with low level 
tetraplegia. 
 α 0.8920 No evidence 
found. 
No evidence 
found. 
Convergent: correlation with Upper 
Extremity Motor Score r=0.8220 
Concurrent/discriminant: progressive 
(‘dose response’) mean scores by ASIA 
motor level group (all but one - C7 vs C8 
- statistically significant from other group 
scores).20  
No evidence found. 
         
Spinal Cord 
Independence 
Measure (SCIM) 
21 
~10 (all 
versions) 
2 No evidence
found. 
 No evidence 
found. 
K range 0.66 - 
0.7344 
Total 
agreement 
85%. K 
range 0.66 - 
0.9821 
Convergent: correlation between SCIM 
and FIM r =0.85 p<0.01.21 
Superior 
responsiveness to 
FIM suggested, 
although some 
contradictory 
findings.21;52 
         
Catz-Itzkovich 
revised SCIM  
(SCIM II) 52 
 
 2    K range 0.4 - 
0.6, r =0.78 - 
0.86 
p<0.000144 
Convergent: correlation between SCIM 
II and FIM r =0.84 p<0.001.48 
Construct: Rasch model identified flaws 
including: Wheelchair-car transfer 
showed misfit and multidimensionality. 
Respiration also showed misfit. A 
number of taskss’ scores exhibited 
disordered thresholds.70 
 
Catz-Itzkovich 
revised SCIM  
(SCIM III)3 
 2 Floor effect of 
mobility 
subscale.3 
α >0.722 ICC 0.94 to 
0.97; K values 
0.63 to 0.82 
(p<0.001) 22 
 Construct: Rasch model: confirmed 
unidimensionality for 3 subscales. Misfit 
identified in ‘walking outdoors’ & ‘stair 
management’ items of mobility 
subscale, &  ‘toilet use’ within 
respiration/sphincter (RS) subscale. RS 
subscale had disordered category 
thresholds with some items eg. bowel 
management.3 22. 
Superior 
responsiveness to 
FIM.53 
/Table 2 continued 
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RELIABILITY 
 
VALIDITY 
 
 
 
Instrument 
 
No. of 
published 
studies where 
instrument 
used with SCI 
patients 
 
 
 
Ease of use 
1-3a
 
 
 
Floor (Fb )/ 
Ceiling (C) 
effects 
Internal 
consistency 
(Cronbach’s 
alpha(α)) 
Test/re-test 
(ICC) or 
Kappa (K) 
Inter-rater 
or inter-
observer  
 
Construct, convergent, concurrent  
or discriminant.. 
 
RESPONSIVENESS/ 
SENSITIVITY 
 
         
 
Walking Index 
for Spinal cord 
injury (WISCI) 
23/ WISCI-II66 
>5   1 Ceiling effect
at 6 months 
from SCI onset 
chiefly in 
relation to. 
walking 
function.
 No evidence 
found. 
39 
No evidence 
found. 
Rating 
videotaped 
patients. 
Kendall 
coefficient of 
concordance 
(W) =0.87 
p<0.001.23 
Convergent: Stat signif correlation 
r=0.77 (p<0.001) with FIM.23 
Construct: High/significant correlations 
range r= -0.88 or -0.89 with 3 timed 
measures of ambulation.67 
Convergent Stat signif correlations 
range r=0.48 to 0.88 in change scores 
with LEMS, LFIM, FIM & Berg Balance 
scale.39;50 
Convergent: Stat signif correlations (all 
p<0.001) with BI and  Rivermead 
mobility index (RMI)  both r=0.67, SCIM 
r=0.97, LEMS r=0.58 & FIM r=0.7.49 
Superior responsive-
ness to LFIM & SCIM 
may simply reflect 
measurement of 
different domains.39 
Limited evidence  
WISCI has superior 
sensitivity to walking 
recovery than the BI, 
RMI, SCIM, LEMS or 
FIM - comparing 
distribution of 
scores.49 
 
Needs 
Assessment 
Checklist (NAC) 
24 
~5  1 No evidence
found. 
 Mean α 0.86 
all scales 
>0.7.24 α 
range 0.7 to 
0.9 43 
Correlations 
range r=0.69 
bladder, to 
0.90 for skin 
management 
p≤ 0.01.24 
No evidence 
found. 
Convergent: Statistically significant 
correlations range 0.47 to 0.85 (p≤ 0.01) 
with SCIM & Hospital Anxiety & 
Depression Scale (HADS).24 
No evidence found. 
 
The Spinal 
Cord Injury 
Functional 
Ambulation 
inventory (SCI-
FAI)25 
1 1 - for  an 
experienced
physio-
therapist 
No evidence 
found. 
No evidence 
found. 
ICC =0.70, 
0.80 & 0.84 for 
live video 
sessions (VS) 
1 and 2 ratings 
respectively.25 
No evidence 
found. 
Convergent: Correlations between gait 
score and walking speed: r= -0.74 and -
0.70 for VS1 and VS2 respectively; & 
with sel port of walking ability: r=0.70. 
Pre- & p t-training correlation with 
LEMS w  r=0.74 & 0.64 respectively.25 
Limited evidence of 
sensitivity: %change 
in gait score 
significantly related 
to change in LEMS.25 
 
The SIP6837  
 
~2   1 Ceiling effects
with 3 scales: 
psych autonom
 
y
& 
communication, 
emotional 
stability, mobility
range.35 
α range 0.72 
(emotional 
stability) to 
0.85 (mobility 
control).37 
α range 0.68 
(emotional 
stability) to 
0.91.34 
ICC Scores 
range 0.61 to 
0.90.35 
ICC for 
index-proxy 
pairs range 
0.26 (mental 
health) to 
0.85 (somatic 
autonomy).35 
Constru Factor analysis (sample 
contain SCI patients) : 6 factor 
solution here original SIP71, had had 
12 subs es.37  
Conver t: Stat signif correlations with 
relevan -36 scales (phys func r= -
0.66, m al health r= - 0.57) & ADL 
(somati utonomy r=0.81)35; & with BI 
(som au  -0.91, mobility range r= -
0.54)34 
Conver t: Stat signif correlations with 
level of ion for subscales som aut (r= 
-0.72), ility control (r= -0.47). 
Remain  scales range r= -0.07 
(emotio  stability ) to r= -0.39 (mobility 
range).
No evidence in SCI 
context. 
a 1=rated as ‘very straightforward’ to apply and score, 2=’moderately straightforward’, 3=’complex’ requiring considerable training. 
b clusters of scores near the lower limit of the data in a study 
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